Do you want to read an article? Please log in or register.
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
Asthma
RECOMMENDED
Related content
RECOMMENDED
Further Publications
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Agrawal U, Katikireddi SV, McCowan C, Mulholland RH, Azcoaga-Lorenzo A, Amele S, Fagbamigbe AF, Vasileiou E, Grange Z, Shi T, Kerr S, Moore E, Murray JLK, Shah SA, Ritchie L, O'Reilly D, Stock SJ, Beggs J, Chuter A, Torabi F, Akbari A, Bedston S, McMenamin J, Wood R, Tang RSM, de Lusignan S, Hobbs FDR, Woolhouse M, Simpson CR, Robertson C, Sheikh A
doi: 10.1016/S2213-2600(21)00380-5
Respiratory Tract Infection
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
Lancet
Vasileiou E, Simpson CR, Shi T, Kerr S, Agrawal U, Akbari A, Bedston S, Beggs J, Bradley D, Chuter A, de Lusignan S, Docherty AB, Ford D, Hobbs FR, Joy M, Katikireddi SV, Marple J, McCowan C, McGagh D, McMenamin J, Moore E, Murray JL, Pan J, Ritchie L, Shah SA, Stock S, Torabi F, Tsang RS, Wood R, Woolhouse M, Robertson C, Sheikh A
doi: 10.1016/S0140-6736(21)00677-2
RECOMMENDED
Respiratory Tract Infection
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
★ 3
Recommended by
Dr Martin Frey, Faculty Member
N Engl J Med
Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Benavides AG, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Isaacs MB, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A, AstraZeneca AZD1222 Clinical Study Group.
doi: 10.1056/NEJMoa2105290
COMMENTED
Further Publications
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, Minassian AM, Cho I, Kumar L, Plested JS, Rivers EJ, Robertson A, Dubovsky F, Glenn G, Heath PT, 2019nCoV-302 Study Group.
doi: 10.1016/S2213-2600(21)00409-4
RECOMMENDED
Further Publications
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Docherty AB, Mulholland RH, Lone NI, Cheyne CP, De Angelis D, Diaz-Ordaz K, Donegan C, Drake TM, Dunning J, Funk S, García-Fiñana M, Girvan M, Hardwick HE, Harrison J, Ho A, Hughes DM, Keogh RH, Kirwan PD, Leeming G, Nguyen Van-Tam JS, Pius R, Russell CD, Spencer RG, Tom BD, Turtle L, Openshaw PJ, Baillie JK, Harrison EM, Semple MG, ISARIC4C Investigators.
doi: 10.1016/S2213-2600(21)00175-2
RECOMMENDED
Pneumonia
Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1183/13993003.00524-2020.
RECOMMENDED
Pneumonia
COVID-19
One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Swiss Med Wkly
Betschart M, Rezek S, Unger I, Ott N, Beyer S, Böni A, Gisi D, Shannon H, Spruit MA, Sieber C
doi: 10.4414/smw.2021.w30072
RECOMMENDED
Asthma
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, Carson G, Dunning J, Harrison EM, Baillie JK, Semple MG, Cullinan P, Openshaw PJM, ISARIC investigators.
doi: 10.1016/S2213-2600(21)00013-8
Pneumonia
Comparison of Acute Kidney Injury in Patients with COVID-19 and Other Respiratory Infections: A Prospective Cohort Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Diebold M, Zimmermann T, Dickenmann M, Schaub S, Bassetti S, Tschudin-Sutter S, Bingisser R, Heim C, Siegemund M, Osswald S, Kuster GM, Rentsch KM, Breidthardt T, Twerenbold R
doi: 10.3390/jcm10112288